Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation

Nguyen, HK; Humber, D; Checkoway, H; Blanchard, D; Watanabe, JH

Watanabe, JH (reprint author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Div Clin Pharm, 9500 Gilman Dr,MC 0764, La Jolla, CA 92093 USA.

CONSULTANT PHARMACIST, 2018; 33 (9): 521

Abstract

BACKGROUND: Oral anticoagulants (OACs) are recommended for nonvalvular atrial fibrillation (NVAF) patients with moderate-to high-stroke risk. OBJECTIV......

Full Text Link